Literature DB >> 28146652

Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis.

David C Knox1, Peter L Anderson2, P Richard Harrigan3, Darrell H S Tan4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28146652     DOI： 10.1056/NEJMc1611639

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  52 in total

Review 1.  Drug Resistance During HIV Pre-Exposure Prophylaxis.

Authors:  Kevin M Gibas; Polly van den Berg; Victoria E Powell; Douglas S Krakower
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

2.  Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.

Authors:  Stephanie E Cohen; Darpun Sachdev; Sulggi A Lee; Susan Scheer; Oliver Bacon; Miao-Jung Chen; Hideaki Okochi; Peter L Anderson; Mary F Kearney; Susa Coffey; Hyman Scott; Robert M Grant; Diane Havlir; Monica Gandhi
Journal:  Lancet HIV       Date:  2018-11-29       Impact factor: 12.767

Review 3.  Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation.

Authors:  Victoria E Powell; Kevin M Gibas; Joshua DuBow; Douglas S Krakower
Journal:  Curr Infect Dis Rep       Date:  2019-06-21       Impact factor: 3.725

4.  Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial.

Authors:  Raphael J Landovitz; Sue Li; Joseph J Eron; Beatriz Grinsztejn; Halima Dawood; Albert Y Liu; Manya Magnus; Mina C Hosseinipour; Ravindre Panchia; Leslie Cottle; Gordon Chau; Paul Richardson; Mark A Marzinke; Susan H Eshleman; Ryan Kofron; Adeola Adeyeye; David Burns; Alex R Rinehart; David Margolis; Myron S Cohen; Marybeth McCauley; Craig W Hendrix
Journal:  Lancet HIV       Date:  2020-06-01       Impact factor: 12.767

Review 5.  Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions.

Authors:  Matthew A Spinelli; Jessica E Haberer; Peter R Chai; Jose Castillo-Mancilla; Peter L Anderson; Monica Gandhi
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

Review 6.  The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.

Authors:  Anna Zhukova; Teresa Cutino-Moguel; Olivier Gascuel; Deenan Pillay
Journal:  J Infect Dis       Date:  2017-12-01       Impact factor: 5.226

7.  HIV Preexposure Prophylaxis and Condomless Sex: Disentangling Personal Values From Public Health Priorities.

Authors:  Sarah K Calabrese; Kristen Underhill; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2017-08-17       Impact factor: 9.308

Review 8.  Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.

Authors:  Jessica L Adams; Karishma Shelley; Melanie R Nicol
Journal:  Pharmacotherapy       Date:  2019-04-01       Impact factor: 4.705

9.  CROI 2017: HIV Epidemic Trends and Advances in Prevention.

Authors:  Albert Y Liu; Susan P Buchbinder
Journal:  Top Antivir Med       Date:  2017 May/Jun

Review 10.  Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.

Authors:  Sarah E Rutstein; Dawn K Smith; Shona Dalal; Rachel C Baggaley; Myron S Cohen
Journal:  Lancet HIV       Date:  2020-08-27       Impact factor: 12.767
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.